483
Intersect ENT, Inc.Intersect ENT, Inc. – FDA 483, Nov 3, 2017
Record Details
An FDA inspection of Intersect ENT, Inc. in Menlo Park, CA, a sterile finished drug-device combination product manufacturer, revealed significant deficiencies. Observations included inadequate validation of manufacturing processes and computer systems, incomplete batch production records, and insufficient employee training for visual inspections. These issues indicate a lack of robust quality control and compliance with regulatory requirements.
View Company Profile
ID · 9eabbc8a-088f-43ea-8144-020728ec98c7
Other documents for Intersect ENT, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.